Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ziskind

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Genetics|May 1, 1996
A novel deletion at codon 441 of the APC gene associated with ophthalmic lesions (CHRPE) in a South African familyJ J Grobbelaar, A Ziskind, G de Jong, et al.
The American Journal of Cardiology|August 15, 1991
Cardiac transplantation for giant coronary artery aneurysms complicating Kawasaki diseaseJ M Travaline, S M Hamilton, R E Ringel, et al.
American Heart Journal|April 1, 1994
Late presentation of left ventricular pseudoaneurysm and ventricular septal defect after surgery for penetrating cardiac injuryR H Schwengel, S K Bennett, A J Sequeira, et al.
Catheterization and Cardiovascular Diagnosis|August 1, 1992
Antegrade selective coronary angiography via the transseptal approach in a patient with severe vascular diseaseA C Pearce, R H Schwengel, L M Simione, et al.
Circulation|January 1, 1990
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibitionI K Jang, H K Gold, A A Ziskind, et al.
Journal of Medical Economics|May 3, 2018
A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximabShoshana R Daniel, John D McDermott, Cathy Le, et al.
American Heart Journal|January 1, 1993
Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfacesC D Riemann, C V Massey, D L McCarron, et al.
The American Journal of Cardiology|June 15, 1994
Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratoryA A Ziskind, J Portelli, S Rodriguez, et al.
Circulation|February 1, 1989
Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosisA A Ziskind, H K Gold, T Yasuda, et al.
Circulation|April 1, 1989
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysisI K Jang, H K Gold, A A Ziskind, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Genetics|May 1, 1996
A novel deletion at codon 441 of the APC gene associated with ophthalmic lesions (CHRPE) in a South African familyJ J Grobbelaar, A Ziskind, G de Jong, et al.
The American Journal of Cardiology|August 15, 1991
Cardiac transplantation for giant coronary artery aneurysms complicating Kawasaki diseaseJ M Travaline, S M Hamilton, R E Ringel, et al.
American Heart Journal|April 1, 1994
Late presentation of left ventricular pseudoaneurysm and ventricular septal defect after surgery for penetrating cardiac injuryR H Schwengel, S K Bennett, A J Sequeira, et al.
Catheterization and Cardiovascular Diagnosis|August 1, 1992
Antegrade selective coronary angiography via the transseptal approach in a patient with severe vascular diseaseA C Pearce, R H Schwengel, L M Simione, et al.
Circulation|January 1, 1990
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibitionI K Jang, H K Gold, A A Ziskind, et al.
Journal of Medical Economics|May 3, 2018
A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximabShoshana R Daniel, John D McDermott, Cathy Le, et al.
American Heart Journal|January 1, 1993
Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfacesC D Riemann, C V Massey, D L McCarron, et al.
The American Journal of Cardiology|June 15, 1994
Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratoryA A Ziskind, J Portelli, S Rodriguez, et al.
Circulation|February 1, 1989
Synergistic combinations of recombinant human tissue-type plasminogen activator and human single-chain urokinase-type plasminogen activator. Effect on thrombolysis and reocclusion in a canine coronary artery thrombosis model with high-grade stenosisA A Ziskind, H K Gold, T Yasuda, et al.
Circulation|April 1, 1989
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysisI K Jang, H K Gold, A A Ziskind, et al.
Pageof 4